Aurobindo Pharma Q1FY25 results: Net profit jumps 61% to Rs 919 cr

Q: How long will it take to read this news story?

The story "Aurobindo Pharma Q1FY25 results: Net profit jumps 61% to Rs 919 cr" has 199 words across 6 sentences, which will take approximately 1 - 2 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Aurobindo Pharma Q1FY25 results: Net profit jumps 61% to Rs 919 cr" was covered 9 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 117 news stories per day. It's most recent story was published 5 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #22007031</li><li>URL: https://beamstart.com/news/aurobindo-pharma-q1fy25-results-net-17233038784286</li></ul>

Business Standard Logo Business Standard 9h ago

Aurobindo Pharma Q1FY25 results: Net profit jumps 61% to Rs 919 cr - Business Standard

Quick Summary:

Aurobindo Pharma on Saturday said its consolidated net profit increased 61 per cent year on year to Rs 919 crore in the first quarter ended June 2024, aided by strong sales across markets.

"We are pleased with our continued strong performance this quarter, with a significant top-line growth across all our business segments," Aurobindo Pharma Vice-Chairman and Managing Director K Nithyananda Reddy stated.

Revenue from operations increased to Rs 7,567 crore in the June quarter as against Rs 6,851 crore in the year-ago period, the drug maker said in a statement.